(Q64377412)
Statements
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer (English)
Suzane Trudel
Ants Toi
Zhi Hua Li
Michael Jewett
John Tshilias
Li Hue Zhuang
Mary Hitt
Yonghong Wan
Jack Gauldie
Frank L Graham
Janet Dancey
A Keith Stewart
1 October 2003